Advertisement
Persons > United Kingdom (GB)
Please find below persons from the United Kingdom (GB) or related to British organisations.Total search results: 2826 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Varley, John (AstraZeneca 200607) | n. a. | AstraZeneca (Group) | East of England (region) |
Vasarotti, Enzo (Vivascience 200008 founder + co-partner) | Company Founder | Sartorius (Group) | East Midlands (region) |
Vaschetto, Mariana (Dotmatics 201307 VP Marketing) | n. a. | Insightful Science (Group) | East of England (region) |
Vaughan, Tris (AstraZeneca 201808 VP RnD Antibody Discovery + Protein Engineering at MedImmuune) | Research & Development Manager | AstraZeneca (Group) | Maryland (federal state) |
Vellacott, Richard (Horizon Discovery 201207– CFO before VP Finance at CSR plc before Deloitte) | Chief Financial Officer (CFO) | PerkinElmer (Group) | East of England (region) |
Venables, David (Laverock Therapeutics 202309 CEO formerly Synpromics 201508 CEO) | Chief Executive Officer (CEO) | Laverock Therapeutics Ltd. | East of England (region) |
Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) | Chief Executive Officer (CEO) | Quercis Pharma (Group) | Central Switzerland (region) |
Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Ori Biotech (Oribiotech) (Group) | Greater London (region) |
Verheyen, Jeroen (Semarion 201808– CEO + Co-Founder) | Chief Executive Officer (CEO) | Semarion Ltd. | East of England (region) |
Vernon, N. Geoffrey | n. a. | Ziggus Holding Ltd. | United Kingdom (state/region unspecified) |
Vesey, John (United Kingdom (govt) 201905 Business Manager Health at Satellite Applications Catapult) | Business Development Manager / Strategy Manager | United Kingdom (GB) (govt) | South East England (region) |
Viant, Mark (Univ Birmingham 201303 Professor) | Professor | University of Birmingham | West Midlands (region) |
Vicary, James (NuNano 201711 Managing Director + Co-Founder) | Managing Director | NuNano (GB) | South West England (region) |
Vidian, Armen (DCVC 2020 Partner) | Partner (venture partner) | DCVC (Data Collective) (Group) | California (federal state) |
Viehbacher, Christopher A. (Chris) (Biogen 202307 CEO before Gurnet Point Capital + Sanofi + GSK) | Managing Partner | BERTARELLI Group (family of Ernesto Bertarelli) | Channel Islands (Non-Commonwealth / Non-EU tax haven) |
Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | Greater London (region) |
Villette, Astrid (FTI Consulting 201612 FTI Consulting Paris) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | Île-de-France (region) |
VInce, Valérie (KWS Biotest 201511– Business Development Manager joined 2008 before Imperial College London) | Business Development Manager / Strategy Manager | Charles River (Group) | South West England (region) |
Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
Vogel, Daniel (Genomics plc 202010– CFO before Carwow + Compare Global Group + Goldman Sachs) | Chief Financial Officer (CFO) | Genomics plc | South East England (region) |
Volmer, Dietrich (Saarland Univ 201005– Professor for Analytical Chemistry before Univ Cambridge before Dalhousie Univ) | Professor | Saarland University (Universität des Saarlandes) | Saarland (federal state) |
von Jako, Ron (GE Healthcare 200807 CMO + Surgical Developm Leader) | Chief Medical Officer (CMO) | General Electric (Group) | South East England (region) |
von Will, Tristana (Biochrom Ltd 201306 Product Marketing Manager) | Sales Manager / Marketing Manager | Harvard Bioscience (Group) | East of England (region) |
Vosloo, Mark (Techcomp 201310– CEO of Edinburgh Instruments before Linos Photonics Ltd + Horiba Jobin Yvon Ltd) | Chief Executive Officer (CEO) | Techcomp (Group) | Scotland |
Vosloo, Nicola (PerkinElmer 201102 PerkinElmer (UK) Ltd) | n. a. | PerkinElmer (Group) | South East England (region) |
Wade-Gery, Laura (Marks & Spencer + Tesco) | Board member, non-executive | Adaptimmune (Group) | South East England (region) |
Wagner, David (GSK 201005 Section Manager DMPK Group) | n. a. | GSK (Group) | Greater London (region) |
Wake, Ashleigh (Intertek 201509 Biopharmaceutical Services Leder) | President/Director/Head Business Group/Unit/Division | Intertek (Group) | North West England (region) |
Walder, Adrienne (Alto Marketing 201010 Account Director) | Public Relations Manager / Investor Relations Manager | Alto Marketing Ltd. | South East England (region) |
Walker, Anthony (Alacrita 2009– Founding Partner before Onyvax CEO + co-founder before consultant) | Company Founder | Alacrita (Group) | Greater London (region) |
Walker, Cheri (Abcam 201911 SVP Corp Development formerly Charles River+ Qiagen + Invitrogen + Deutsche Bank) | Business Development Manager / Strategy Manager | Abcam (Group) | East of England (region) |
Walker, Jerry (Lab21 –200710– CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | South East England (region) |
Walker, Paul (Spectris 201309 Managing Director of Malvern Instruments Ltd) | Managing Director | Spectris (Group) | West Midlands (region) |
Walker, Ross (Oxford RF Sensors 200506 CEO) | Chief Executive Officer (CEO) | Oxford NanoLabs Ltd. | South East England (region) |
Walker, Sarah (OBN 201905 Senior Events Manager) | Event Manager / Conference Manager | OBN (UK) Ltd. | South East England (region) |
Wall, Jane (BIA 202401– Managing Director before Business Development + Membership Services) | Managing Director | BioIndustry Association (BIA) (GB) | Greater London (region) |
Wallace, Paul (Mission Therapeutics 201503– CBO before Medivir AB Head of Business Development) | Chief Business Officer (CBO) | Mission Therapeutics Ltd. | East of England (region) |
Wallace, Paul (QCMD 201310 Managing Director) | Managing Director | Quality Control for Molecular Diagnostics Ltd. (QCMD) | Scotland |
Wallace, Wallace (Univ Oxford 202203– Associate LS at Oxford Science Enterprises before M Ventures + Accenture) | venture capital | Oxford Science Enterprises (Group) | South East England (region) |
Waller, John (OracleBio 201111 Director) | President/Director/Head Business Group/Unit/Division | OracleBio Ltd. | Scotland |
Wallis, Tim (Ridgeway Biologicals 201701 Managing Director) | Managing Director | Klocke (Group) | South East England (region) |
Walls, Matthew (EpiStem 200704 CEO) | Chief Executive Officer (CEO) | Genedrive (Group) | North West England (region) |
Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (state/region unspecified) |
Walport, Mark (Wellcome Trust 2010 Director) | n. a. | Wellcome Trust, The | Greater London (region) |
Walsh, Andrew (Cambridge Enterprise 200804 Technology Manager) | IP Manager | University of Cambridge | East of England (region) |
Walsh, Jeremy (Cambridge Respiratory Innovations 201804 CEO) | Chief Executive Officer (CEO) | Cambridge Respiratory Innovations (GB) | East of England (region) |
Walters, Esmé (Zyme Communications 202301) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | East of England (region) |
Walters, Julie (Tudor Reilly 2007– Managing Director + Founder) | Managing Director | Tudor Reilly Ltd. (Tudor Reilly Health) | Greater London (region) |
Walton, Luke (Univ Warwick 201905 International Press Manager) | Public Relations Manager / Investor Relations Manager | University of Warwick | West Midlands (region) |
Walts, Alan (Advent Life Sciences 201702 Venture Partner) | Partner (venture partner) | Advent Life Sciences LLP | Greater London (region) |
Wang, Wenyong (Adaptimmune 201604– VP Business Development before Evolution Life Science Partners + Burrill Secutiries) | Business Development Manager / Strategy Manager | Adaptimmune (Group) | South East England (region) |
Wang, Zilong (Allen) (HEL Group 202302– promoted to General Manager of H.E.L. China before Malvern Pananalytical) | General Manager (management) | HEL (H.E.L.) (Group) | Beijing (Peking) (province) |
Warburton, Elaine (QuantuMDx 200803– CEO + Co-founder before Opaldia CEO) | Chief Executive Officer (CEO) | QuantuMDx (Group) | North East England (region) |
Warburton, Mark (Cyprotex 201608 COO + Legal Counsel) | Chief Operating Officer (COO) | Evotec (Group) | North West England (region) |
Ward, Andrew (FTI Consulting 201808) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | Greater London (region) |
Ward, Barrie (Board Member at several companies in 2012 before CEO of Kudos) | Board member, non-executive | CellCentric Ltd. | East of England (region) |
Ward, Malcolm (Proteome Sciences 201009 CTO) | Chief Technology/Technical Officer (CTO) | Proteome Sciences (Group) | South East England (region) |
Ward, Maya (Gresham House 202104 Associate Director at Gresham House Ventures) | Investment Manager | Gresham House (Group) | Greater London (region) |
Ward, Penelope (Virion Biotherapeutics 201811– CMO before UCB + GSK + Roche + Pharmacia & Upjohn) | Chief Medical Officer (CMO) | Virion Biotherapeutics Ltd. | Greater London (region) |
Ward, Sean (Synthace 201708 CTO) | Chief Technology/Technical Officer (CTO) | Synthace (Group) | Greater London (region) |
Ward-Lilley, James (Vectura 201603 CEO) | Chief Executive Officer (CEO) | Vectura (Group) | South West England (region) |
Wardle, Kay (Coulter Partners 201712) | Human Resources Manager | Coulter Partners (The Coulter Partnership Ltd.) | Greater London (region) |
Wareing, Clare (Cumulus Oncology 202002 CEO + Founder) | Chief Executive Officer (CEO) | Cumulus Oncology Ltd. | Scotland |
Warne, Mark (IP Group 201411 Healthcare Portfolio Director + Activiomics 201004 Interim CEO) | Investment Manager | IP Group (Group) | Greater London (region) |
Warren, Jeremy (NanoSight Ltd 201309 CEO) | Chief Executive Officer (CEO) | Spectris (Group) | South West England (region) |
Warren, Katie (Sciad Communications 202011) | Public Relations Manager / Investor Relations Manager | Sciad Communications Ltd. | Greater London (region) |
Warren, Lee (RoslinCT 202204– CFO before Cobra Biologics) | Chief Financial Officer (CFO) | RoslinCT (Group) | Scotland |
Wass, Ed (Catapult Ventures 201509) | Investment Manager | Catapult Ventures (Group) | East Midlands (region) |
Waterfield, Mike (Piramed 200605 Co-founder) | Company Founder | Roche (Group) | South East England (region) |
Waterfield, Nick R. (Warwick Univ Medical School 202012 + Co-Founder NanoSyrinx) | Professor | University of Warwick | West Midlands (region) |
Waterhouse, Deborah (ViiV Healthcare 201907 CEO) | Chief Executive Officer (CEO) | GSK (Group) | Greater London (region) |
Waterhouse, Oliver J. (Base Genomics 201907– CEO + Founder) | Chief Executive Officer (CEO) | Exact Sciences (Group) | South East England (region) |
Waterman, Sally (OBN 2014–201812 Board Chairman) | Board member, non-executive | OBN (UK) Ltd. | South East England (region) |
Waterworth, Toby Wilson (Atlantic Healthcare plc 201603 CEO) | Chief Executive Officer (CEO) | Atlantic Healthcare plc | East of England (region) |
Watkin, David J. (Univ Oxford 201009 Dept Chemistry Director Chemical Crystallography Lab) | Researcher (university / research institute) | University of Oxford | United Kingdom (state/region unspecified) |
Watson, Dave (Univ Strathclyde 201003 Prof + ScotMet) | Professor | University of Strathclyde (Glasgow) | Scotland |
Watson, David (Lhasa Ltd 201302 CEO) | Chief Executive Officer (CEO) | Lhasa Ltd. | Yorkshire and the Humber (region) |
Watson, Lorna (Northbank Communications 200608 Senior Account Manager) | n. a. | Instinctif Partners (Group) | Greater London (region) |
Watson, Michael (VaxEquity 202109 Executive Chairman) | Board member, executive | VaxEquity Ltd. (VXT) | East of England (region) |
Watson, Nicola (Schauenburg 201412 at Markes international) | n. a. | Schauenburg (Group) | Wales |
Watson, Tim (Instinctif Partners 201807) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NodThera Ltd. | East of England (region) |
Watt, Fiona (Univ Cambridge 201203 Professor of Molecular Genetics) | Professor | University of Cambridge | East of England (region) |
Watts, Sam (Stratophase 201110 Business Development + Commercial Officer + co-founder) | Business Development Manager / Strategy Manager | Stratophase Ltd. | South East England (region) |
Watts, Tim (Oxford BioMedica 2012–201709 CFO RETIRED 9/17) | Chief Financial Officer (CFO) | Oxford Biomedica (Group) | South East England (region) |
Weaver, Richard (XenoGesis 201109– Managing Director + Founder before AstraZeneca R&D) | Managing Director | Sygnature Discovery (Group) | East Midlands (region) |
Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice) | Chief Executive Officer (CEO) | Congenica (Group) | East of England (region) |
Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) | Chief Executive Officer (CEO) | EKF Diagnostics (Group) | Greater London (region) |
Webb, Mike (Delta Diagnostics (UK) 201310– Operations Director + Co-owner before Hologic + Gen-Probe + Tepnel) | General Manager (management) | Yourgene Health (Group) | North West England (region) |
Webber, Guy (Quotient Bioresearch 201003 Head of In Vitro Sciences) | n. a. | Quotient Bioresearch (Group) | East of England (region) |
Wedlake, Bill (NextPharma 200301– CEO before CFO since 7/00) | Chief Executive Officer (CEO) | NextPharma (Group) | South East England (region) |
Weedon, Dimitrios (OrbiMed 202305– Managing Director in new London Office) | Managing Director | OrbiMed (Group) | Greater London (region) |
Wei, Liangshen (Horizon Discovery 201611 Head of Emerging Markets Team) | Business Development Manager / Strategy Manager | PerkinElmer (Group) | East of England (region) |
Weinberger, Paul (Lumora 201005– Chief Marketing Officer before Roche Diagnostics + Enigma Diagnostics) | Sales Manager / Marketing Manager | Erba Diagnostics Mannheim (Group) | East of England (region) |
Weinstein, Edward (Horizon Discovery 201607 President of Services Business) | President/Director/Head Business Group/Unit/Division | PerkinElmer (Group) | East of England (region) |
Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983) | Chief Executive Officer (CEO) | Sosei (Group) | East of England (region) |
Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | South East England (region) |
Wells, Glenn (Wellcome Trust 200809 BusDev Manager) | Business Development Manager / Strategy Manager | Wellcome Trust, The | Greater London (region) |
Welsh, Chris (Consilium Strategic Communications 201707) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | Greater London (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top